

DIAGNOSTIC SERVICES
Hereditary Cancer
Since 2019, the NCCN guidelines recommended Comprehensive Multi-genes testing over single genes testing when more than one gene can explain an inherited cancer syndrome. Comprehensive Multi-gene testing is superior to one or a few genes testing for many reasons, some common advantages of comprehensive panel testing include:
- Results will provide a more comprehensive assessment of the genes associated with cancer in a family.
- It is more efficient and cost-effective because some insurance companies will not cover repeat testing if single/limited gene testing results are negative.
- The clinical presentations of various hereditary cancer syndromes can overlap, so allows for simultaneous evaluation of multiple genes or syndromes.
A negative result on a multi-gene panel is more reassuring than a negative result for one or a few genes. In addition, panel testing can identify a syndrome that was not the first differential and may have been missed with single gene/limited gene testing
Oncomine Myeloid Panel
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Comprehensive
Hereditary Cancer Gene List
Ataxia-telangiectasia/Hereditary Breast & Ovarian Cancer (HBOC) Syndrome
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome
Juvenile Polyposis Syndrome (JPS) & Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome/Fanconi Anemia
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome/Fanconi Anemia
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome/ Nijmegen breakage syndrome
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome/Fanconi Anemia
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome/Fanconi Anemia
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome
Hereditary Breast & Ovarian Cancer (HBOC) Syndrome/Li-Fraumeni Syndrome (LFS)/Renal Cell Carcinoma